Clinigen Healthcare (LON:CLIN) declared a dividend on Tuesday, February 27th, Upcoming.Co.Uk reports. Investors of record on Thursday, March 22nd will be given a dividend of GBX 1.76 ($0.02) per share on Thursday, April 12th. This represents a yield of 0.2%. The ex-dividend date of this dividend is Thursday, March 22nd. The official announcement can be accessed at this link.
Shares of Clinigen Healthcare stock traded up GBX 28.50 ($0.40) during trading hours on Friday, reaching GBX 928.50 ($13.03). The stock had a trading volume of 355,934 shares, compared to its average volume of 432,646. Clinigen Healthcare has a 1 year low of GBX 751.50 ($10.55) and a 1 year high of GBX 1,187 ($16.66).
Clinigen Healthcare (LON:CLIN) last released its quarterly earnings data on Tuesday, February 27th. The company reported GBX 21.20 ($0.30) EPS for the quarter, topping analysts’ consensus estimates of GBX 20.30 ($0.28) by GBX 0.90 ($0.01). Clinigen Healthcare had a return on equity of 8.14% and a net margin of 7.15%. The company had revenue of £167.80 million for the quarter.
A number of equities research analysts have recently issued reports on CLIN shares. Berenberg Bank upgraded Clinigen Healthcare to a “buy” rating and increased their target price for the company from GBX 1,200 ($16.84) to GBX 1,220 ($17.13) in a research note on Thursday, January 18th. Numis Securities reiterated an “add” rating and issued a GBX 1,208 ($16.96) target price on shares of Clinigen Healthcare in a research note on Wednesday, January 17th. Peel Hunt restated a “buy” rating and set a GBX 1,350 ($18.95) price objective on shares of Clinigen Healthcare in a research note on Thursday, February 1st. Finally, N+1 Singer restated a “buy” rating and set a GBX 1,225 ($17.20) price objective on shares of Clinigen Healthcare in a research note on Wednesday, January 17th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of GBX 1,212.17 ($17.02).
TRADEMARK VIOLATION NOTICE: “Clinigen Healthcare (CLIN) Announces GBX 1.76 Dividend” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/08/clinigen-group-plc-clin-to-go-ex-dividend-on-march-22nd.html.
Clinigen Healthcare Company Profile
Clinigen Group plc operates as a specialty pharmaceutical and services company. Its Clinigen Clinical Trial Services segment supplies and manages commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs, and rescue therapies. The company's Idis Managed Access segment is involved in the consultancy, development, management, and implementation of managed access programs for biotechnology and pharmaceutical companies.
Receive News & Ratings for Clinigen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.